CK1 Inhibitor

AAT 5, ACVRLK 4, ALK-5, Activin A receptor type II like kinase, Activin A receptor type II like kinase 53kDa, Activin A receptor type II like kinase, 53kD, Activin receptor-like kinase 5, CDC-like kinase 1, CDC28/CDC2 like kinase, CLK/STY, CLK1_HUMAN, CSAID Binding Protein 1, CSAID-binding protein, CSBP, CSBP 1, CSBP 2, CSPB1, Csaids binding protein, Cytokine suppressive anti-inflammatory drug-binding protein, Dual specificity protein kinase CLK1, EXIP, KPCD1_HUMAN, LDS1A, LDS2A, MAP kinase 14, MAP kinase MXI2, MAP kinase p38 alpha, MAPK 14, MAX-interacting protein 2, MK14_HUMAN, MSSE, Mitogen-activated protein kinase 14, Mitogen-activated protein kinase p38 alpha, Mxi 2, P38, PKC, PKC MU, PKCM, PKD, PRKCM, PRKD 1, PRKM14, PRKM15, Protein kinase C mu, Protein kinase C mu type, Protein kinase D, Protein kinase D1, Protein tyrosine kinase STY, RK, SAPK2A, SKR 4, STY, Serine/threonine-protein kinase D1, Serine/threonine-protein kinase receptor R4, Stress-activated protein kinase 2a, TGF-beta receptor type I, TGF-beta receptor type-1, TGF-beta type I receptor, TGFBR 1, TGFBR1 protein, TGFR1_HUMAN, TbetaR-I, Transforming growth factor beta receptor 1, Transforming growth factor beta receptor I, Transforming growth factor beta receptor I (activin A receptor type II like kinase, 53kD), Transforming growth factor-beta receptor type I, activin A receptor type II-like protein kinase of 53kD, nPKC-D1, nPKC-mu, p38 ALPHA, p38 MAP kinase, p38 MAPK, p38 mitogen activated protein kinase, p38alpha Exip

Biochemicals